Connect
Description
In this webinar, Mayo Clinic neurosurgeon Ian Parney, M.D., PhD, and neurologist Alyx Porter, M.D., discuss the diagnosis, management, treatment and recovery associated with adult brain tumors. Topics include: management and treatment options, such as surgery, radiation, chemotherapy and clinical trials, as well as recovery and quality of life. A question and answer session followed the presentation.
Would you like to:
Like
Helpful
Hug
Connect
Thanks-where can we see this over again?
I am idh1 and 2 wild type egfr positive methylated and pten ( one mutation exon 8) top 01 and top2a positive I am in the process of finishing the stupp protocol ( 4th week) and I am considering using the optune hat is this a good choice i am 75 years old ( 90 % resected left frontal parietal gbm) or is there another clinical trial which would be more effective?
is having one mutation in pten ( exon 8) a bad indicator for gbm I read having one mutation is a precancer sign?
what are your thoughts on tocagen for gbm?
How do we test and apply for the 1 CEU ??
Dear pvolkert - Unfortunately we are not offering CEU credits with these webinars. thank you!
Dear Patti B - The can be viewed again here on this landing page and it will be uploaded to YouTube as well.
It sounds as though this company in San Diego has clinical trials available for patients with high grade glioma. There are several academic centers participating in those trials. It may be worthwhile to check their website to see if a center near you is participating.
Not necessarily. The whole genetic profile must be taken into consideration.
Optune is only covered by insurance companies at this point for recurrent disease. Clinical trials are available for use upfront, but you would have had to enroll prior to initiation of your treatment with Stupp.